Health Trials

CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome

2

Review clinical trials related to CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

This study intends to conduct a prospective single-center open single-arm multi-dose escalation study on therapeutic immunological agent treatment in patients with Lymphoproliferative disease associated with EBV to observe the safety and efficacy.

Participants needed: 27
Trial details
Phase: Phase 1Age: 2-70Biological sex: AllType: InterventionalSponsor: West China HospitalUpdated: Oct 30, 2024Locations: 1
Eligibility criteria

Persistent or recurrent infectious IM-like symptoms lasting for more than 3 mont... [+2]

For CAEBV patients and others with EBV-LPD 1). Participated in other drug clinic... [+1]

Read more
Status: Not yet recruiting

A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

To evaluate the efficacy and safety of iNK cells infusion in patients with chronic active Epstein-Barr virus infection (CAEBV) and EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Participants needed: 15
Trial details
Age: Up to 65Biological sex: AllType: InterventionalSponsor: Beijing Friendship HospitalUpdated: Jul 11, 2024Locations: 1
Eligibility criteria

≤65 years，ECOG :0-2； [+4]

Patients with evidence of grade II or more serious heart disease according to th... [+4]

Read more